{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:29:37Z","timestamp":1784687377405,"version":"3.55.0"},"reference-count":32,"publisher":"Society of Nuclear Medicine","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med.\n                Technol."],"accepted":{"date-parts":[[2025,10,2]]},"published-print":{"date-parts":[[2025,12]]},"DOI":"10.2967\/jnmt.125.270826","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T13:40:17Z","timestamp":1764855617000},"page":"4S-12S","source":"Crossref","is-referenced-by-count":3,"title":["The Current Practice of Theranostics: Results of a National Survey and Lessons Learned"],"prefix":"10.2967","volume":"53","author":[{"given":"Victoria","family":"West","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Morse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Mallak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2025121109350929000_53.Supplement_1.4S.1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-22-2875","article-title":"FDA approval summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer","volume":"29","author":"Fallah","year":"2023","journal-title":"Clin Cancer Res."},{"key":"2025121109350929000_53.Supplement_1.4S.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2025121109350929000_53.Supplement_1.4S.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2025121109350929000_53.Supplement_1.4S.4","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00259-025-07103-7","article-title":"Radiotheranostic landscape: a review of clinical and preclinical development","volume":"52","author":"Tran","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025121109350929000_53.Supplement_1.4S.5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/cancers14030761","article-title":"Treatment of neuroendocrine neoplasms with radiolabeled peptides: where are we now","volume":"14","author":"Naik","year":"2022","journal-title":"Cancers (Basel)."},{"key":"2025121109350929000_53.Supplement_1.4S.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268363"},{"key":"2025121109350929000_53.Supplement_1.4S.7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/HP.0000000000001644","article-title":"Clinical best practices for radiation safety during lutetium-177 therapy","volume":"124","author":"Cappon","year":"2023","journal-title":"Health Phys."},{"key":"2025121109350929000_53.Supplement_1.4S.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06255-8"},{"key":"2025121109350929000_53.Supplement_1.4S.9","first-page":"539","article-title":"Practical guidance on [177Lu]Lu-PSMA-617 treatment, including radiation safety, adverse event monitoring, and patient counseling","volume":"27","author":"Spitz","year":"2023","journal-title":"Clin J Oncol Nurs."},{"key":"2025121109350929000_53.Supplement_1.4S.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.230607"},{"key":"2025121109350929000_53.Supplement_1.4S.11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1148\/radiol.2020201745","article-title":"How we do it: a multidisciplinary approach to 177Lu DOTATATE peptide receptor radionuclide therapy","volume":"298","author":"Burkett","year":"2021","journal-title":"Radiology."},{"key":"2025121109350929000_53.Supplement_1.4S.12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3390\/pharmaceutics15041240","article-title":"Safety and therapeutic optimization of lutetium-177 based radiopharmaceuticals","volume":"15","author":"Ladri\u00e8re","year":"2023","journal-title":"Pharmaceutics."},{"key":"2025121109350929000_53.Supplement_1.4S.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.122.263813"},{"key":"2025121109350929000_53.Supplement_1.4S.14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MPA.0000000000002002","article-title":"Best practices for the coordinated care of patients with neuroendocrine tumors undergoing peptide receptor radionuclide therapy","volume":"51","author":"Hendifar","year":"2022","journal-title":"Pancreas."},{"key":"2025121109350929000_53.Supplement_1.4S.15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3390\/biomedicines9040430","article-title":"177Lu-PSMA therapy in metastatic castration-resistant prostate cancer","volume":"9","author":"Sanli","year":"2021","journal-title":"Biomedicines."},{"key":"2025121109350929000_53.Supplement_1.4S.16","unstructured":"Endocyte. Protocol no. PSMA-617-01: VISION: an international, prospective, open-label, multicenter, randomized phase 3 study of 177Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). https:\/\/cdn.clinicaltrials.gov\/large-docs\/64\/NCT03511664\/Prot_002.pdf. Published September 14, 2022. Accessed August 31, 2025."},{"key":"2025121109350929000_53.Supplement_1.4S.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.252494"},{"key":"2025121109350929000_53.Supplement_1.4S.18","unstructured":"Pluvicto (lutetium Lu 177 vipivotide tetraxetan) package insert. National Library of Medicine website. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fb973a8d-7fea-4a7a-963f-2a8e67a46e55. Accessed June 25, 2025."},{"key":"2025121109350929000_53.Supplement_1.4S.19","doi-asserted-by":"crossref","first-page":"e6780","DOI":"10.1002\/cam4.6780","article-title":"Establishing a robust radioligand therapy program: a practical approach for North American centers","volume":"13","author":"Mittra","year":"2024","journal-title":"Cancer Med."},{"key":"2025121109350929000_53.Supplement_1.4S.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268522"},{"key":"2025121109350929000_53.Supplement_1.4S.21","doi-asserted-by":"crossref","first-page":"1291253","DOI":"10.3389\/fnume.2023.1291253","article-title":"Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry","volume":"3","author":"Meyer","year":"2023","journal-title":"Front Nucl Med."},{"key":"2025121109350929000_53.Supplement_1.4S.22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00259-023-06536-2","article-title":"Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT\/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study","volume":"51","author":"Neubauer","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025121109350929000_53.Supplement_1.4S.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267665"},{"key":"2025121109350929000_53.Supplement_1.4S.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264677"},{"key":"2025121109350929000_53.Supplement_1.4S.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264398"},{"key":"2025121109350929000_53.Supplement_1.4S.26","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1097\/RLU.0000000000005986","article-title":"The role of SPECT\/CT in 177Lu-PSMA-617 theranostics: case-based review of response and progression patterns","volume":"50","author":"Ghodsi","year":"2025","journal-title":"Clin Nucl Med."},{"key":"2025121109350929000_53.Supplement_1.4S.27","doi-asserted-by":"crossref","first-page":"e240080","DOI":"10.1148\/rg.240080","article-title":"PSMA radiotheranostics in prostate cancer: principles, practice, and future prospects","volume":"44","author":"Szidonya","year":"2024","journal-title":"Radiographics."},{"key":"2025121109350929000_53.Supplement_1.4S.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267606"},{"key":"2025121109350929000_53.Supplement_1.4S.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267955"},{"key":"2025121109350929000_53.Supplement_1.4S.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267830"},{"key":"2025121109350929000_53.Supplement_1.4S.31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40658-024-00658-8","article-title":"A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?","volume":"11","author":"Vergnaud","year":"2024","journal-title":"EJNMMI Phys."},{"key":"2025121109350929000_53.Supplement_1.4S.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2824-5"}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.125.270826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:35:42Z","timestamp":1765474542000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.125.270826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"Supplement 1","published-online":{"date-parts":[[2025,12,4]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.2967\/jnmt.125.270826"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.125.270826","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}